| . | SAT Density (HU) . | VAT Density (HU) . | Adipocyte Diameter (μm2) . |
|---|---|---|---|
| Overall (n = 54) | −100 (−106, −96) | −83 (−89, −78) | 2156 (1909, 2439) |
| BMI category, kg/m2 | |||
| 18.0–24.9 (n = 22) | −96 (−104, −87) | −81 (−84, −78) | 2082 (1919, 2392) |
| 25.0–30.0 (n = 18) | −100 (−102, −97) | −82 (−87, −75) | 2181 (1775, 2364) |
| >30.0 (n = 14) | −106 (−110, −102) | −90 (−95, −85) | 2448 (1909, 2707) |
| P | 0.001 | 0.001 | 0.16 |
| Race or ethnicity | |||
| White, non-Hispanic (n = 21) | −101 (−106, −96) | −89 (−91, −82) | 2306 (1922, 2551) |
| White, Hispanic (n = 15) | −101 (−107, −96) | −83 (−91, −80) | 2098 (1909, 2435) |
| Black (n = 13) | −100 (−105, −96) | −78 (−82, −75) | 2020 (1727, 2321) |
| Other (n = 5) | −97 (−97, −94) | −83 (−83, −78) | 2342 (2056, 2358) |
| P | 0.27 | 0.02 | 0.70 |
| Sex at birth | |||
| Male (n = 48) | −99 (−105, −95) | −83 (−89, −78) | 2156 (1909, 2435) |
| Female (n = 6) | −108 (−108, −105) | −87 (−91, −82) | 2182 (1909, 2524) |
| P | 0.004 | 0.39 | 0.72 |
| CD4+ T lymphocyte count, cells per mm3 | |||
| ≤200 (n = 25) | −100 (−106, −96) | −79 (−87, −75) | 2098 (1930, 2352) |
| >200 (n = 29) | −101 (−106, −95) | −85 (−91, −82) | 2342 (1853, 2664) |
| P | 0.87 | 0.003 | 0.28 |
| HIV-1 RNA, copies per mL | |||
| <100,000 (n = 35) | −101 (−106, −97) | −84 (−90, −76) | 2308 (1922, 2524) |
| ≥100,000 (n = 19) | −97 (−106, −95) | −82 (−87, −78) | 2098 (1824, 2321) |
| P | 0.22 | 0.34 | 0.28 |
| . | SAT Density (HU) . | VAT Density (HU) . | Adipocyte Diameter (μm2) . |
|---|---|---|---|
| Overall (n = 54) | −100 (−106, −96) | −83 (−89, −78) | 2156 (1909, 2439) |
| BMI category, kg/m2 | |||
| 18.0–24.9 (n = 22) | −96 (−104, −87) | −81 (−84, −78) | 2082 (1919, 2392) |
| 25.0–30.0 (n = 18) | −100 (−102, −97) | −82 (−87, −75) | 2181 (1775, 2364) |
| >30.0 (n = 14) | −106 (−110, −102) | −90 (−95, −85) | 2448 (1909, 2707) |
| P | 0.001 | 0.001 | 0.16 |
| Race or ethnicity | |||
| White, non-Hispanic (n = 21) | −101 (−106, −96) | −89 (−91, −82) | 2306 (1922, 2551) |
| White, Hispanic (n = 15) | −101 (−107, −96) | −83 (−91, −80) | 2098 (1909, 2435) |
| Black (n = 13) | −100 (−105, −96) | −78 (−82, −75) | 2020 (1727, 2321) |
| Other (n = 5) | −97 (−97, −94) | −83 (−83, −78) | 2342 (2056, 2358) |
| P | 0.27 | 0.02 | 0.70 |
| Sex at birth | |||
| Male (n = 48) | −99 (−105, −95) | −83 (−89, −78) | 2156 (1909, 2435) |
| Female (n = 6) | −108 (−108, −105) | −87 (−91, −82) | 2182 (1909, 2524) |
| P | 0.004 | 0.39 | 0.72 |
| CD4+ T lymphocyte count, cells per mm3 | |||
| ≤200 (n = 25) | −100 (−106, −96) | −79 (−87, −75) | 2098 (1930, 2352) |
| >200 (n = 29) | −101 (−106, −95) | −85 (−91, −82) | 2342 (1853, 2664) |
| P | 0.87 | 0.003 | 0.28 |
| HIV-1 RNA, copies per mL | |||
| <100,000 (n = 35) | −101 (−106, −97) | −84 (−90, −76) | 2308 (1922, 2524) |
| ≥100,000 (n = 19) | −97 (−106, −95) | −82 (−87, −78) | 2098 (1824, 2321) |
| P | 0.22 | 0.34 | 0.28 |
Median (IQR) reported. P values based on Kruskal-Wallis or Wilcoxon rank-sum tests.
| . | SAT Density (HU) . | VAT Density (HU) . | Adipocyte Diameter (μm2) . |
|---|---|---|---|
| Overall (n = 54) | −100 (−106, −96) | −83 (−89, −78) | 2156 (1909, 2439) |
| BMI category, kg/m2 | |||
| 18.0–24.9 (n = 22) | −96 (−104, −87) | −81 (−84, −78) | 2082 (1919, 2392) |
| 25.0–30.0 (n = 18) | −100 (−102, −97) | −82 (−87, −75) | 2181 (1775, 2364) |
| >30.0 (n = 14) | −106 (−110, −102) | −90 (−95, −85) | 2448 (1909, 2707) |
| P | 0.001 | 0.001 | 0.16 |
| Race or ethnicity | |||
| White, non-Hispanic (n = 21) | −101 (−106, −96) | −89 (−91, −82) | 2306 (1922, 2551) |
| White, Hispanic (n = 15) | −101 (−107, −96) | −83 (−91, −80) | 2098 (1909, 2435) |
| Black (n = 13) | −100 (−105, −96) | −78 (−82, −75) | 2020 (1727, 2321) |
| Other (n = 5) | −97 (−97, −94) | −83 (−83, −78) | 2342 (2056, 2358) |
| P | 0.27 | 0.02 | 0.70 |
| Sex at birth | |||
| Male (n = 48) | −99 (−105, −95) | −83 (−89, −78) | 2156 (1909, 2435) |
| Female (n = 6) | −108 (−108, −105) | −87 (−91, −82) | 2182 (1909, 2524) |
| P | 0.004 | 0.39 | 0.72 |
| CD4+ T lymphocyte count, cells per mm3 | |||
| ≤200 (n = 25) | −100 (−106, −96) | −79 (−87, −75) | 2098 (1930, 2352) |
| >200 (n = 29) | −101 (−106, −95) | −85 (−91, −82) | 2342 (1853, 2664) |
| P | 0.87 | 0.003 | 0.28 |
| HIV-1 RNA, copies per mL | |||
| <100,000 (n = 35) | −101 (−106, −97) | −84 (−90, −76) | 2308 (1922, 2524) |
| ≥100,000 (n = 19) | −97 (−106, −95) | −82 (−87, −78) | 2098 (1824, 2321) |
| P | 0.22 | 0.34 | 0.28 |
| . | SAT Density (HU) . | VAT Density (HU) . | Adipocyte Diameter (μm2) . |
|---|---|---|---|
| Overall (n = 54) | −100 (−106, −96) | −83 (−89, −78) | 2156 (1909, 2439) |
| BMI category, kg/m2 | |||
| 18.0–24.9 (n = 22) | −96 (−104, −87) | −81 (−84, −78) | 2082 (1919, 2392) |
| 25.0–30.0 (n = 18) | −100 (−102, −97) | −82 (−87, −75) | 2181 (1775, 2364) |
| >30.0 (n = 14) | −106 (−110, −102) | −90 (−95, −85) | 2448 (1909, 2707) |
| P | 0.001 | 0.001 | 0.16 |
| Race or ethnicity | |||
| White, non-Hispanic (n = 21) | −101 (−106, −96) | −89 (−91, −82) | 2306 (1922, 2551) |
| White, Hispanic (n = 15) | −101 (−107, −96) | −83 (−91, −80) | 2098 (1909, 2435) |
| Black (n = 13) | −100 (−105, −96) | −78 (−82, −75) | 2020 (1727, 2321) |
| Other (n = 5) | −97 (−97, −94) | −83 (−83, −78) | 2342 (2056, 2358) |
| P | 0.27 | 0.02 | 0.70 |
| Sex at birth | |||
| Male (n = 48) | −99 (−105, −95) | −83 (−89, −78) | 2156 (1909, 2435) |
| Female (n = 6) | −108 (−108, −105) | −87 (−91, −82) | 2182 (1909, 2524) |
| P | 0.004 | 0.39 | 0.72 |
| CD4+ T lymphocyte count, cells per mm3 | |||
| ≤200 (n = 25) | −100 (−106, −96) | −79 (−87, −75) | 2098 (1930, 2352) |
| >200 (n = 29) | −101 (−106, −95) | −85 (−91, −82) | 2342 (1853, 2664) |
| P | 0.87 | 0.003 | 0.28 |
| HIV-1 RNA, copies per mL | |||
| <100,000 (n = 35) | −101 (−106, −97) | −84 (−90, −76) | 2308 (1922, 2524) |
| ≥100,000 (n = 19) | −97 (−106, −95) | −82 (−87, −78) | 2098 (1824, 2321) |
| P | 0.22 | 0.34 | 0.28 |
Median (IQR) reported. P values based on Kruskal-Wallis or Wilcoxon rank-sum tests.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
